RU2016151340A3 - - Google Patents

Download PDF

Info

Publication number
RU2016151340A3
RU2016151340A3 RU2016151340A RU2016151340A RU2016151340A3 RU 2016151340 A3 RU2016151340 A3 RU 2016151340A3 RU 2016151340 A RU2016151340 A RU 2016151340A RU 2016151340 A RU2016151340 A RU 2016151340A RU 2016151340 A3 RU2016151340 A3 RU 2016151340A3
Authority
RU
Russia
Application number
RU2016151340A
Other versions
RU2016151340A (ru
RU2720680C2 (ru
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of RU2016151340A publication Critical patent/RU2016151340A/ru
Publication of RU2016151340A3 publication Critical patent/RU2016151340A3/ru
Application granted granted Critical
Publication of RU2720680C2 publication Critical patent/RU2720680C2/ru

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841Filling excipients; Inactive ingredients
    • A61K9/4858Organic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445Non condensed piperidines, e.g. piperocaine
    • A61K31/4523Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/454Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. pimozide, domperidone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/53751,4-Oxazines, e.g. morpholine
    • A61K31/53771,4-Oxazines, e.g. morpholine not condensed and containing further heterocyclic rings, e.g. timolol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
RU2016151340A 2014-06-18 2015-06-16 Новая фармацевтическая композиция, содержащая неионные сурфактанты RU2720680C2 (ru)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
EP14173023.4 2014-06-18
EP14173023 2014-06-18
EP14174664 2014-06-27
EP14174664.4 2014-06-27
PCT/EP2015/063469 WO2015193309A1 (en) 2014-06-18 2015-06-16 New pharmaceutical composition comprising non-ionic surfactants

Publications (3)

Publication Number Publication Date
RU2016151340A RU2016151340A (ru) 2018-07-19
RU2016151340A3 true RU2016151340A3 (ru) 2019-01-23
RU2720680C2 RU2720680C2 (ru) 2020-05-12

Family

ID=53385665

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2016151340A RU2720680C2 (ru) 2014-06-18 2015-06-16 Новая фармацевтическая композиция, содержащая неионные сурфактанты

Country Status (11)

Country Link
US (2) US20170119781A1 (ru)
EP (1) EP3157569B1 (ru)
JP (1) JP6831704B2 (ru)
KR (1) KR102379639B1 (ru)
CN (2) CN106456556A (ru)
BR (1) BR112016024421A2 (ru)
CA (1) CA2942186C (ru)
MX (1) MX2017015936A (ru)
RU (1) RU2720680C2 (ru)
TW (1) TWI694827B (ru)
WO (1) WO2015193309A1 (ru)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
LT3345903T (lt) * 2009-06-10 2019-12-10 Chugai Pharmaceutical Co Ltd Tetracikliniai junginiai
CA2808210C (en) 2010-08-20 2019-10-01 Chugai Seiyaku Kabushiki Kaisha Tetracyclic compounds having alk inhibitory activity and compositions thereof
ES2692664T3 (es) 2012-09-25 2018-12-04 Chugai Seiyaku Kabushiki Kaisha Inhibidor de RET
WO2015163448A1 (ja) 2014-04-25 2015-10-29 中外製薬株式会社 4環性化合物を高用量含有する製剤
TWI765410B (zh) 2014-08-08 2022-05-21 日商中外製藥股份有限公司 4環性化合物的非晶質體的用途
TWI752901B (zh) 2015-01-16 2022-01-21 日商中外製藥股份有限公司 合併用醫藥
CN109254102B (zh) * 2017-07-14 2022-02-15 上海联陆实业股份有限公司 一种水溶性维生素e衍生物的高效液相检测方法
SG11202100983XA (en) 2018-09-04 2021-03-30 Chugai Pharmaceutical Co Ltd Method of producing tetracyclic compound
CN112218626B (zh) * 2019-12-31 2023-03-24 广州帝奇医药技术有限公司 一种持续释放组合物及其制备方法

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS4891218A (ru) * 1972-03-06 1973-11-28
MEP89008A (en) * 2001-10-19 2011-12-20 Novel cyclosporin analog microemulsion preconcentrates
ITRM20030074A1 (it) * 2003-02-21 2004-08-22 Pharmacia Italia Spa Formulazioni semisolide a rilascio immediato intese
EP1880715A1 (en) * 2006-07-19 2008-01-23 Abbott GmbH & Co. KG Pharmaceutically acceptable solubilizing composition and pharmaceutical dosage form containing same
WO2008078922A1 (en) * 2006-12-22 2008-07-03 Yuhan Corporation Revaprazan-containing solid dispersion and process for the preparation thereof
JP2010516704A (ja) * 2007-01-22 2010-05-20 ノババックス,インコーポレイテッド 摂食/絶食による変動性を低減し、かつ経口バイオアベイラビリティーを改善するための難水溶性薬物の多相医薬製剤
MX2009011681A (es) * 2007-05-18 2009-11-10 Scidose Llc Formulaciones de ziprasidona.
CN101138550B (zh) * 2007-09-18 2012-06-27 沈阳药科大学 多种表面活性剂联合使用制备的混合胶束药物制剂及其制备方法
DE102007058504A1 (de) * 2007-12-05 2009-07-09 Acino Ag Transdermales therapeutisches System mit einem Gehalt an einem Modulator für nikotinische Acetylcholinrezeptoren (nAChR)
AR071375A1 (es) * 2008-04-22 2010-06-16 Solvay Pharm Gmbh Formulaciones para ingredientes farmaceuticos activos de permeabilidad deficiente, proceso de preparacion y producto
TWI471321B (zh) * 2009-06-08 2015-02-01 Abbott Gmbh & Co Kg Bcl-2族群抑制劑之口服醫藥劑型
LT3345903T (lt) * 2009-06-10 2019-12-10 Chugai Pharmaceutical Co Ltd Tetracikliniai junginiai
NZ602288A (en) * 2010-03-10 2014-02-28 Abbvie Bahamas Ltd Solid compositions comprising amorphous (2r,6s,13as,14ar,16as,z)-n-(cyclopropylsulfonyl)-6-(5-methylpyrazine-2-carboxamido)-5,16-dioxo-2-(phenanthridin-6-yloxy)-1,2,3,5,6,7,8,9,10,11,13a,14,14a,15,16,16a-hexadecahydrocyclopropa[e]pyrrolo[1,2-a][1,4]diazacyclopentadecine-14a-carboxamide
WO2011117711A1 (en) * 2010-03-22 2011-09-29 Glenmark Pharmaceuticals S.A. Pharmaceutical composition comprising a pyrimidineone derivative
GB201010954D0 (en) * 2010-06-29 2010-08-11 Edko Pazarlama Tanitim Ticaret Compositions
CA2808210C (en) * 2010-08-20 2019-10-01 Chugai Seiyaku Kabushiki Kaisha Tetracyclic compounds having alk inhibitory activity and compositions thereof
WO2012138783A2 (en) * 2011-04-04 2012-10-11 Netherlands Cancer Institute Methods and compositions for predicting resistance to anticancer treatment

Also Published As

Publication number Publication date
CN110960500A (zh) 2020-04-07
BR112016024421A2 (pt) 2017-08-15
KR20170020783A (ko) 2017-02-24
TW201625262A (zh) 2016-07-16
CA2942186A1 (en) 2015-12-23
TWI694827B (zh) 2020-06-01
EP3157569B1 (en) 2019-07-24
KR102379639B1 (ko) 2022-03-28
MX2017015936A (es) 2018-04-18
RU2016151340A (ru) 2018-07-19
EP3157569A1 (en) 2017-04-26
US20170119781A1 (en) 2017-05-04
CN106456556A (zh) 2017-02-22
RU2720680C2 (ru) 2020-05-12
US20200397794A1 (en) 2020-12-24
CN110960500B (zh) 2022-10-14
JP6831704B2 (ja) 2021-02-17
JP2017518341A (ja) 2017-07-06
CA2942186C (en) 2023-06-27
WO2015193309A1 (en) 2015-12-23

Similar Documents

Publication Publication Date Title
BR112016027956A2 (ru)
BR112016027117A2 (ru)
BR112016015311A2 (ru)
BR112016022255A2 (ru)
BR112016018800A2 (ru)
BR112016018965A2 (ru)
RU2016151340A3 (ru)
BR112016021645A2 (ru)
BR112016004202A2 (ru)
BR112016027032A2 (ru)
BR112016021783A2 (ru)
BR112016021681A2 (ru)
JP1529600S (ru)
CN302715051S (ru)
CN302721213S (ru)
CN302714811S (ru)
CN302713952S (ru)
CN302705789S (ru)
CN302711530S (ru)
CN302704857S (ru)
CN302701578S (ru)
CN302705837S (ru)
CN302706920S (ru)
CN302709710S (ru)
CN302708523S (ru)